Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Connick

Showing results (31-40 of 33) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 33 results.
The Journal of Infectious Diseases|December 23, 1999
Immune reconstitution in the first year of potent antiretroviral therapy and its relationship to virologic responseE Connick, M M Lederman, B L Kotzin, et al.
Journal of Virology|October 24, 2000
Reduced susceptibility of human immunodeficiency virus type 1 (HIV-1) from patients with primary HIV infection to nonnucleoside reverse transcriptase inhibitors is associated with variation at novel amino acid sitesA J Brown, H M Precious, J M Whitcomb, et al.
JAMA|September 29, 1999
Reduced antiretroviral drug susceptibility among patients with primary HIV infectionS J Little, E S Daar, R T D'Aquila, et al.
Pageof 4

Showing results (31-40 of 33) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 33 results.
The Journal of Infectious Diseases|December 23, 1999
Immune reconstitution in the first year of potent antiretroviral therapy and its relationship to virologic responseE Connick, M M Lederman, B L Kotzin, et al.
Journal of Virology|October 24, 2000
Reduced susceptibility of human immunodeficiency virus type 1 (HIV-1) from patients with primary HIV infection to nonnucleoside reverse transcriptase inhibitors is associated with variation at novel amino acid sitesA J Brown, H M Precious, J M Whitcomb, et al.
JAMA|September 29, 1999
Reduced antiretroviral drug susceptibility among patients with primary HIV infectionS J Little, E S Daar, R T D'Aquila, et al.
Pageof 4